menu
    • menu

    Company profile for Syncromune

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Syncromune is a privately held, clinical-stage biopharmaceutical company focused on developing an innovative in situ platform therapy tailored for metastatic solid tumor cancers. The company's flagship product, SYNC-T, is a personalized therapy combining partial tumor oncolysis with a multi-target biologic drug. This novel approach aims to achieve high response rates and potentially improve survival outcomes by targeting multi...
    Syncromune is a privately held, clinical-stage biopharmaceutical company focused on developing an innovative in situ platform therapy tailored for metastatic solid tumor cancers. The company's flagship product, SYNC-T, is a personalized therapy combining partial tumor oncolysis with a multi-target biologic drug. This novel approach aims to achieve high response rates and potentially improve survival outcomes by targeting multiple cancer mechanisms, enhancing immune activation at the tumor site, and overcoming immunosuppression.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SyncromuneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2919 E Commercial Blvd 2919 E Commercial Blvd, Fort Lauderdale, FL 33308
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://syncromune.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/syncromune/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Syncromune To Present Phase 1 Data On Bone Metastases
    Syncromune To Present Phase 1 Data On Bone Metastases

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191868/0/en/Syncromune-Inc-to-Present-Phase-1-Data-Highlighting-Resolution-of-Bone-Metastases-in-Metastatic-Prostate-Cancer-Patients-at-the-Society-of-Urological-Oncology-26th-Annual-Meeting.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    Syncromune Presents Ph1 SV-102 Prostate Cancer Data At ASCO
    Syncromune Presents Ph1 SV-102 Prostate Cancer Data At ASCO

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3091859/0/en/Syncromune-Inc-Presents-Positive-Results-from-SYNC-T-Therapy-SV-102-Phase-1-Metastatic-Prostate-Cancer-Trial-at-ASCO-2025.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share
    Syncromune Announces 1st Patient Dosed in LEGION-100 Ph 2a Trial
    Syncromune Announces 1st Patient Dosed in LEGION-100 Ph 2a Trial

    30 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/30/3091053/0/en/Syncromune-Announces-First-Patient-Dosed-in-LEGION-100-Phase-2a-Trial-of-SYNC-T-Therapy-SV-102-for-Patients-with-Metastatic-Castration-Resistant-Prostate-Cancer.html

    GLOBENEWSWIRE
    30 May 2025
    Share Share
    Syncromune Announces Abstract on SYNC-T Therapy SV-102 Phase
    Syncromune Announces Abstract on SYNC-T Therapy SV-102 Phase

    23 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/23/3087456/0/en/Syncromune-Inc-Announces-Publication-of-Abstract-on-SYNC-T-Therapy-SV-102-Phase-1-Data-for-Metastatic-Prostate-Cancer-at-ASCO-2025-Annual-Meeting.html

    GLOBENEWSWIRE
    23 May 2025
    Share Share
    Syncromune to Present Clinical Data from SV-102 Phase 1 Trial
    Syncromune to Present Clinical Data from SV-102 Phase 1 Trial

    25 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/25/3068293/0/en/Syncromune-Inc-to-Present-Clinical-Data-from-SYNC-T-Therapy-SV-102-Phase-1-Trial-at-the-American-Society-for-Clinical-Oncology-Annual-Meeting-2025.html

    GLOBENEWSWIRE
    25 Apr 2025
    Share Share
    Syncromune Appoints Zhihong Li as Chief Regulatory Affair Officer
    Syncromune Appoints Zhihong Li as Chief Regulatory Affair Officer

    25 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/25/3048720/0/en/Syncromune-Appoints-Zhihong-Li-Ph-D-as-Chief-Regulatory-Affairs-Officer-to-Lead-Global-Regulatory-Strategy-for-Novel-Oncology-Immunotherapies.html

    GLOBENEWSWIRE
    25 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search